This is a StreetInsider.com Premium Only Page

Emergent BioSolutions (EBS) – StreetInsider.com Reports

Mar 28, 2024 08:15 AM Emergent BioSolutions (EBS) Continues to Broaden Access, Awareness and Availability of NARCAN Nasal Spray

Mar 7, 2024 10:13 AM Benchmark Upgrades Emergent BioSolutions (EBS) to Buy

Feb 21, 2024 07:03 AM Emergent BioSolutions (EBS) Appoints Industry Leader Joseph C. Papa as New President and CEO

Jan 16, 2024 02:35 PM Emergent BioSolutions (EBS) PT Lowered to $5.50 at Singular Research

Jan 11, 2024 08:00 AM Emergent BioSolutions (EBS) Wins $235.8M Contract to Supply BioThrax to US DoD

Nov 24, 2023 07:30 AM Emergent BioSolutions (EBS) Receives NYSE Notice Regarding Delayed Form 10-Q Filing

Nov 20, 2023 03:59 AM JPMorgan Reinstates Emergent BioSolutions (EBS) at Underweight

Nov 9, 2023 04:34 AM Emergent BioSolutions (EBS) Reports Q3 results; updates guidance

Oct 5, 2023 07:46 AM Emergent BioSolutions (EBS) Issues Statement on Camden Manufacturing Facility Regulatory Status

Sep 1, 2023 04:48 AM Increasing unusual call option volume: EDR MSOS EBS TIO HA GSAT ATUS

Aug 30, 2023 08:48 AM Emergent BioSolutions (EBS) gains as OTC NARCAN launches

Aug 30, 2023 05:59 AM Emergent BioSolutions' (EBS) NARCAN Nasal Spray Launches Over the Counter

Aug 29, 2023 06:18 AM Benchmark Downgrades Emergent BioSolutions (EBS) to Hold, 'Restructuring Plans to Slow Share Price Rebound'

Aug 21, 2023 06:02 PM Kenvue to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600

Aug 21, 2023 05:41 PM After-hours movers: Fabrinet, Zoom gain following earnings results

Aug 21, 2023 05:28 PM Kenvue (KVUE) To Replace Advance Auto Parts (AAP) In S&P 500

Aug 21, 2023 05:21 PM Advance Auto Parts (AAP) Dropped from the S&P 500

Aug 16, 2023 04:53 PM Emergent BioSolutions (EBS) Announces Passing of Director Jerome Hauer

Aug 8, 2023 04:45 PM Emergent BioSolutions (EBS) Misses Q2 EPS by 43c

Aug 8, 2023 07:16 AM Emergent BioSolutions (EBS) Announces Strategic Steps to Strengthen Core Business and Financial Position

Jul 31, 2023 05:21 PM After-hours movers: ZoomInfo sinks on weak guidance, Arista Networks gains on results

Jul 31, 2023 04:08 PM Emergent BioSolutions (EBS) Awarded 10-Year BARDA Contract Valued at up to $704M

Jul 21, 2023 05:41 AM Emergent BioSolutions (EBS) Receives FDA Approval for CYFENDUS

May 30, 2023 07:39 AM Emergent BioSolutions (EBS) receives contract modification from HHS for smallpox vaccine

May 19, 2023 08:47 AM Emergent BioSolutions (EBS) PT Lowered to $15 at TD Cowen

May 9, 2023 05:00 PM Emergent BioSolutions (EBS) Reports Q1 Loss of $3.17

Apr 20, 2023 11:42 AM Emergent aims to price over-the-counter Narcan at about $50

Apr 10, 2023 06:19 AM Benchmark Upgrades Emergent BioSolutions (EBS) to Buy, 'NARCAN OTC Gains Nod'

Mar 29, 2023 01:58 PM Midday movers: Lululemon Athletica, Micron, Emergent Biosolutions and more

Mar 29, 2023 12:17 PM US FDA approves over-the-counter sale of overdose reversal drug Narcan

Mar 29, 2023 09:49 AM Emergent BioSolutions (EBS) Confirms U.S. FDA Approves Over-the-Counter Designation for NARCAN Nasal Spray

Mar 29, 2023 09:06 AM FDA Approves First Over-the-Counter Naloxone Nasal Spray from Emergent BioSolutions (EBS)

Mar 17, 2023 05:49 AM JPMorgan Downgrades Emergent BioSolutions (EBS) to Underweight

Feb 28, 2023 01:27 PM Emergent BioSolutions (EBS) PT Lowered to $21 at Singular Research

Feb 27, 2023 04:44 PM Emergent BioSolutions (EBS) Misses Q4 EPS by 35c; Offers FY23 Revenue Guidance

Feb 17, 2023 11:06 AM Emergent BioSolutions (EBS) PT Raised to $36 at Singular Research

Feb 16, 2023 08:06 AM Emergent BioSolutions shares jump after FDA advisory committee votes in favor of NARCAN

Feb 15, 2023 05:47 PM After-hours movers: Emergent Bio. jumps on FDA panel backing for OTC Narcan, Roku gains on EPS

Feb 15, 2023 05:29 PM Emergent BioSolutions (EBS) confirms FDA AdComm votes in favor of OTC NARCAN

Feb 15, 2023 05:04 PM Emergent BioSolutions (EBS) gains 14% as FDA panel backs OTC use of its opioid overdose drug

Feb 15, 2023 05:03 PM FDA Panels Recommend Nod For Emergent BioSolutions (EBS) Nonprescription Narcan - Bloomberg

Feb 15, 2023 06:00 AM Emergent BioSolutions (EBS) Sells Travel Vaccines Portfolio to Bavarian Nordic for Up to $380M

Jan 26, 2023 10:28 AM FDA identifies recall of Emergent's decontamination kits as most serious

Jan 10, 2023 03:39 PM U.S. FDA panel to review Emergent's OTC opioid overdose drug

Jan 9, 2023 06:59 AM Emergent BioSolutions (EBS) Announces Organizational Changes

Jan 6, 2023 05:54 AM Emergent BioSolutions (EBS) Wins $379.6M Procurement Contract to Supply RSDL to US DoD

Dec 6, 2022 06:36 AM Emergent BioSolutions (EBS) Announces FDA Accepts sNDA for OTC NARCAN

Nov 14, 2022 06:31 AM Emergent BioSolutions (EBS) Announces DoD Award to Evaluate Chikungunya Vaccine Candidate in Post-Approval Field Efficacy Study Using Model-Guided Approach

Nov 11, 2022 07:38 AM Emergent BioSolutions (EBS) PT Lowered to $23 at JPMorgan

Nov 10, 2022 03:37 PM Singular Research Downgrades Emergent BioSolutions (EBS) to Buy-Long Term